Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,022 public trials 2,030 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

NCT05338892

Conditions
Chronic Disease, Diffuse Large B-cell Lymphoma, Disease Attributes, +20 more
Locations
  • Regeneron Research Facility Graz, Austria
  • Regeneron Research Facility Caen, France
  • Regeneron Research Facility Paris, France
  • Regeneron Research Facility Pierre-Bénite, France
View Trial Details
Completed

Study to Evaluate t(11;14) Status and BCL2 Expression in Adult Participants With Multiple Myeloma (MM)

NCT04721002

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations
  • Tulane School of Medicine /ID# 223864 New Orleans, Louisiana, United States
  • University of Texas Southwestern Medical Center /ID# 223865 Dallas, Texas, United States
  • Hospital Italiano de Buenos Aires /ID# 224153 Ciudad Autonoma Buenos Aires, Buenos Aires F.D., Argentina
  • Alfred Health /ID# 224386 Melbourne, Victoria, Australia
View all 40 locations
View Trial Details
Completed

Real-World Clinical Outcomes in Adult Patients Who Initiate Systemic Treatment for Relapsed or Refractory Follicular Lymphoma

NCT05338879

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
Locations
  • Regeneron Research Facility Graz, Austria
  • Regeneron Research Facility Caen, France
  • Regeneron Research Facility Paris, France
  • Regeneron Research Facility Pierre-Bénite, France
View Trial Details
Completed

A Study to Evaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

NCT02005471

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • University of California San Diego Medical Center La Jolla, California, United States
  • Henry Ford Health System Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center; Clinical Trials Office New York, United States
  • Perlmutter Cancer Center NYU Langone Health New York, United States
View all 111 locations
View Trial Details
Completed

Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

NCT02780804

Conditions
Brain Diseases, Brain Neoplasms, Brain Stem Neoplasm, +30 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • UCSF Medical Center-Mission Bay San Francisco, California, United States
View all 21 locations
View Trial Details
Completed

Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas

NCT02304458

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Immune System Diseases, +53 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Children's Hospital of Orange County Orange, California, United States
  • Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
View all 25 locations
View Trial Details

Related conditions